Circovac

Authorised

This medicine is authorised for use in the European Union

adjuvanted inactivated vaccine against porcine circovirus type 2

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website

Circovac : EPAR - Summary for the public

Reference Number: EMA/286116/2007

Product information

Circovac : EPAR - Product Information

Circovac : EPAR - All Authorised presentations

Product details

• Name of medicine:
  Circovac
• Active substance:
  inactivated porcine circovirus type 2 (PCV2)
• International non-proprietary name (INN) or common name:
  adjuvanted inactivated vaccine against porcine circovirus type 2

Pharmacotherapeutic group

Immunologicals for suidae

Authorisation details

• EMA product number:
  EMEA/V/C/000114
• Marketing authorisation holder:
  CEVA-Phylaxia Zrt.

  Szállás Utca 5 ; 1107 Budapest ; Hungary

Assessment history

Changes since initial authorisation of medicine

Circovac : EPAR - Procedural steps taken and scientific information after authorisation

Circovac-V-C-000114-WS1945-0018 : EPAR - Assessment report - Variation

Adopted Reference Number: EMA/564312/2021

CVMP post-authorisation summary of positive opinion for Circovac

Adopted Reference Number: EMA/CVMP/223810/2010

Initial marketing authorisation documents

Circovac : EPAR - Procedural steps taken before authorisation

Circovac : EPAR - Scientific Discussion